News

The Medicines Company has received European approval for the use of Angiox (bivalirudin) as an anticoagulant in patients with heart attacks (ST-segment elevation myocardial infarction (STEMI)) undergoing emergency

Provectus has presented preliminary data for PH-10 Phase 2 clinical trial for psoriasis as well as for its Phase 2 clinical trial for atopic dermatitis. According to the

China Sky One Medical (the Company) has entered into distribution agreement with Guangdong Mediacy Kind (MDK) engaging MDK to serve as its exclusive sales agent for the company’s

Genetic Analysis has launched GA-map microarray test for high throughput screening of infant gut microbiota. The company presented data from evaluation screens that show its potential as a

Genzyme has initiated shipping vials of newly produced Cerezyme (imiglucerase for injection) manufactured at Allston Landing plant. The company also provided an update on its progress to restore

The Angel Fund, The ALS Therapy Alliance and Project ALS have financed a new collaboration between ALS researchers of UMMS and RXi Pharmaceuticals (Rxi). Reportedly, Robert Brown, chair

TriCore has evaluated Roche´s new Magna Pure 96 System for use in nucleic acid purification. The evaluation focused on the Roche system’s ability to process specimens for pathogen

US Nonwovens (USN) has reported a new, patent-pending product. The single-use instant Hand Sanitising Gel Cards, which kills 99.9% of germs. The company claims that the new technology

PPD (Pharmaceutical Product Development) has completed its acquisition of BioDuro. With this acquisition, PPD now employs more than 1,400 in Asia Pacific and nearly 1,000 people in China,